glp-1 forums Nu-U.Ai glp-1 forum GLP-1 and Gut
Description
Semaglutide 2.4 mg, beyond robust weight reduction and improvements in surrogate markers of CVD, such as lipids and glucose, is now associated with benefits for hard CV outcomes CV death, nonfatal MI and nonfatal stroke. Additionally, while presenting cardiometabolic outcomes for retatrutide, Jastreboff said participants who received the 12 mg dose also experienced a mean 40% reduction in triglyceride levels and a mean 22% reduction in LDL cholesterol at 48 weeks, in addition to reductions in HbA1c and blood pressure

Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: a nationwide, population-based cohort study

Up to 86% of participants on tirzepatide achieved an A1C of less than 7%

Modulation of taste sensitivity by GLP-1 signaling in taste buds